Cosmetics Adverse Events Under Spotlight In FDA Transparency Push

FDA’s release of AER data removes some secrecy surrounding cosmetic product adverse events but could create a false alarm about the industry. The data dump comes as Congress is considering legislation that would mandate that cosmetics firms provide FDA with reports of serious adverse events they receive.

FDA entrance sign 2016

In a move to increase transparency, FDA released more than 12 years of data that highlights cosmetic adverse event reports as Congress considers legislation that would mandate reporting of serious adverse events associated with the products.

Announced in a notice prepared for the Dec. 7 Federal Register, the Center for Food Safety and Applied...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Ingredients & Safety

More from HBW Insight